(Updated - November 13, 2024 6:52 AM EST)

H.C. Wainwright analyst Andrew Fein downgrades Syros Pharmaceuticals (NASDAQ: SYRS) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE